SSY Group Limited
LJUIF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.17B
Close$
$0.07
82.8% downside
Current Fair Value
82.8% downsideOvervalued by 82.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.17 Billion |
|---|---|
| Enterprise Value | $3.28 Billion |
| Annual dividend | $0.01 |
| Dividend yield | 3.31% |
| Earnings per Share | $0.16 |
| Beta | 0.53 |
| Outstanding Shares | 2,893,862,000 |
Return
| Return on Equity | 14.95% |
|---|---|
| Return on Assets | 8.66% |
| Return on Invested Capital | 13.12% |
Valuation & Multiples
| P/E Ratio | 14.76 |
|---|---|
| PEG | 113.93 |
| Price to Sales | 0.13 |
| Price to Book Ratio | 0.2 |
| Enterprise Value to Revenue | 0.37 |
| Enterprise Value to EBIT | 2.34 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 1.24 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 26, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About SSY Group Limited
5,400 employees
CEO: Ji Guang Qu
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company o...